Longo G - Search Results

1

Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis.

Baudo F, Caimi TM, Redaelli R, De Cataldo F, Somaini G, Rondinara GF, Degasperi A, Bellati G, Belli LS, Ideo G, Morfini M, Longo G. Baudo F, et al. Among authors: longo g. Haemophilia. 1999 Jul;5(4):276-7. doi: 10.1046/j.1365-2516.1999.00306.x. Haemophilia. 1999. PMID: 10469184

2

Single-dose pharmacokinetics of porcine factor VIII (Hyate C).

Hermans C, Owens D, Lilley P, Longo G, Morfini M, Lee CA. Hermans C, et al. Among authors: longo g. Haemophilia. 2002 Jan;8 Suppl 1:33-8. doi: 10.1046/j.1365-2516.2002.00130.x. Haemophilia. 2002. PMID: 11882082

3

Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.

Messori A, Longo G, Matucci M, Morfini M, Ferrini PL. Messori A, et al. Among authors: longo g. Clin Pharmacokinet. 1987 Dec;13(6):365-80. doi: 10.2165/00003088-198713060-00002. Clin Pharmacokinet. 1987. PMID: 3125001 Review.

4

Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion.

Morfini M, Messori A, Longo G. Morfini M, et al. Among authors: longo g. Blood Coagul Fibrinolysis. 1996 Mar;7 Suppl 1:S11-4. Blood Coagul Fibrinolysis. 1996. PMID: 8735791 Review.

5

Comparative evaluation of the pharmacokinetics of three monoclonal factor VIII concentrates.

Morfini M, Mannucci PM, Longo G, Cinotti S, Messori A. Morfini M, et al. Among authors: longo g. Thromb Res. 1991 Feb 1;61(3):285-90. doi: 10.1016/0049-3848(91)90105-6. Thromb Res. 1991. PMID: 1902997 Clinical Trial.

6

Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs.

Messori A, Longo G, Morfini M, Cinotti S, Filimberti E, Giustarini G, Rossi Ferrini P. Messori A, et al. Among authors: longo g. Eur J Clin Pharmacol. 1988;35(6):663-8. doi: 10.1007/BF00637604. Eur J Clin Pharmacol. 1988. PMID: 3148473

7

Pharmacokinetic properties of recombinant factor VIII compared with a monoclonally purified concentrate (Hemofil M). The Recombinate Study Group.

Morfini M, Longo G, Messori A, Lee M, White G, Mannucci P. Morfini M, et al. Among authors: longo g. Thromb Haemost. 1992 Oct 5;68(4):433-5. Thromb Haemost. 1992. PMID: 1448776 Clinical Trial.

8

Hepatitis-free interval after clotting factor therapy in first infused haemophiliacs.

Morfini M, Rafanelli D, Longo G, Messori A, Ferrini PR. Morfini M, et al. Among authors: longo g. Thromb Haemost. 1986 Dec 15;56(3):268-70. Thromb Haemost. 1986. PMID: 3563960

9

Circulating immune complexes in haemophilia and von Willebrand's disease.

Passaleva A, Massai G, Morfini M, Longo G, Rossi Ferrini PL, Ricci M. Passaleva A, et al. Among authors: longo g. Scand J Haematol. 1983 Nov;31(5):466-74. doi: 10.1111/j.1600-0609.1983.tb01545.x. Scand J Haematol. 1983. PMID: 6606214

10

Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand disease.

Morfini M, Mannucci PM, Tenconi PM, Longo G, Mazzucconi MG, Rodeghiero F, Ciavarella N, De Rosa V, Arter A. Morfini M, et al. Among authors: longo g. Thromb Haemost. 1993 Aug 2;70(2):270-2. Thromb Haemost. 1993. PMID: 8236134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

880 results

Search Page

Filters